David J Cote1,2,3, Timothy R Smith4,5, Ursula B Kaiser4,6, Edward R Laws4, Meir J Stampfer7,8,9. 1. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. david_cote@hms.harvard.edu. 2. Pituitary/Neuroendocrine Center, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. david_cote@hms.harvard.edu. 3. Computational Neuroscience Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. david_cote@hms.harvard.edu. 4. Pituitary/Neuroendocrine Center, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. 5. Computational Neuroscience Outcomes Center, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. 6. Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 7. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 8. Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA. 9. Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Abstract
BACKGROUND: The association between alcohol intake and incidence of pituitary adenoma has not been reported previously. We examined this association in three large, prospective cohort studies. METHODS: Using data from the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-Up Study, we computed multivariable-adjusted hazard ratios (MVHR) and 95% confidence intervals (CI) for pituitary adenoma by levels of alcohol intake using Cox proportional hazards regression. RESULTS: We identified 292 incident cases of pituitary adenoma (225 among women, 67 among men) among 235,973 participants with 6,548,732 person-years of follow-up. Compared with intake of ≤ 0.5 g/day, cumulative average alcohol intake in all categories was associated with reduced risk of pituitary adenoma (MVHR = 0.60, 95% CI 0.43-0.83 for 0.5-≤ 2 g/day, MVHR = 0.57, 95% CI 0.41-0.79 for > 2.0-≤ 8.0, MVHR = 0.70, 95% CI 0.47-1.04 for > 8.0-≤ 15.0, and MVHR = 0.51, 95% CI 0.32-0.83 for > 15.0 g/day). Significant inverse findings were present in women and were similar but non-significant in men. For specific alcoholic beverages, inverse associations were statistically significant for total wine (MVHR = 0.58, 95% CI 0.43-0.79 comparing 0.5-≤ 2 to ≤ 0.5 g/day), red wine (MVHR = 0.65, 95% CI 0.46-0.92 comparing 0.5-≤ 2 to ≤ 0.5 g/day), and white wine (MVHR = 0.72, 95% CI 0.53-0.97 comparing 0.5-≤ 2 to ≤ 0.5 g/day). Results were consistent using baseline intake, recent intake, and with an 8-year lag. CONCLUSION: In three prospective cohorts, compared to almost no consumption, alcohol consumption was associated with reduced risk of pituitary adenoma. Sensitivity analyses suggest that these results are unlikely to be the result of reverse causation or diagnostic bias.
BACKGROUND: The association between alcohol intake and incidence of pituitary adenoma has not been reported previously. We examined this association in three large, prospective cohort studies. METHODS: Using data from the Nurses' Health Study, Nurses' Health Study II, and Health Professionals Follow-Up Study, we computed multivariable-adjusted hazard ratios (MVHR) and 95% confidence intervals (CI) for pituitary adenoma by levels of alcohol intake using Cox proportional hazards regression. RESULTS: We identified 292 incident cases of pituitary adenoma (225 among women, 67 among men) among 235,973 participants with 6,548,732 person-years of follow-up. Compared with intake of ≤ 0.5 g/day, cumulative average alcohol intake in all categories was associated with reduced risk of pituitary adenoma (MVHR = 0.60, 95% CI 0.43-0.83 for 0.5-≤ 2 g/day, MVHR = 0.57, 95% CI 0.41-0.79 for > 2.0-≤ 8.0, MVHR = 0.70, 95% CI 0.47-1.04 for > 8.0-≤ 15.0, and MVHR = 0.51, 95% CI 0.32-0.83 for > 15.0 g/day). Significant inverse findings were present in women and were similar but non-significant in men. For specific alcoholic beverages, inverse associations were statistically significant for total wine (MVHR = 0.58, 95% CI 0.43-0.79 comparing 0.5-≤ 2 to ≤ 0.5 g/day), red wine (MVHR = 0.65, 95% CI 0.46-0.92 comparing 0.5-≤ 2 to ≤ 0.5 g/day), and white wine (MVHR = 0.72, 95% CI 0.53-0.97 comparing 0.5-≤ 2 to ≤ 0.5 g/day). Results were consistent using baseline intake, recent intake, and with an 8-year lag. CONCLUSION: In three prospective cohorts, compared to almost no consumption, alcohol consumption was associated with reduced risk of pituitary adenoma. Sensitivity analyses suggest that these results are unlikely to be the result of reverse causation or diagnostic bias.
Authors: Haley Gittleman; Quinn T Ostrom; Paul D Farah; Annie Ondracek; Yanwen Chen; Yingli Wolinsky; Carol Kruchko; Justin Singer; Varun R Kshettry; Edward R Laws; Andrew E Sloan; Warren R Selman; Jill S Barnholtz-Sloan Journal: J Neurosurg Date: 2014-06-13 Impact factor: 5.115
Authors: E Giovannucci; G Colditz; M J Stampfer; E B Rimm; L Litin; L Sampson; W C Willett Journal: Am J Epidemiol Date: 1991-04-15 Impact factor: 4.897
Authors: David J Cote; Claudine M Samanic; Timothy R Smith; Molin Wang; Stephanie A Smith-Warner; Meir J Stampfer; Kathleen M Egan Journal: Eur J Epidemiol Date: 2021-09-04 Impact factor: 12.434
Authors: M Z Braganza; P Rajaraman; Y Park; P D Inskip; N D Freedman; A R Hollenbeck; A Berrington de González; C M Kitahara Journal: Br J Cancer Date: 2013-12-12 Impact factor: 7.640
Authors: Ai Seon Kuan; Jane Green; Cari M Kitahara; Amy Berrington De González; Tim Key; Gillian K Reeves; Sarah Floud; Angela Balkwill; Kathryn Bradbury; Linda M Liao; Neal D Freedman; Valerie Beral; Siân Sweetland Journal: Neuro Oncol Date: 2019-07-11 Impact factor: 12.300
Authors: Laural K English; Jamy D Ard; Regan L Bailey; Marlana Bates; Lydia A Bazzano; Carol J Boushey; Clarissa Brown; Gisela Butera; Emily H Callahan; Janet de Jesus; Richard D Mattes; Elizabeth J Mayer-Davis; Rachel Novotny; Julie E Obbagy; Elizabeth B Rahavi; Joan Sabate; Linda G Snetselaar; Eve E Stoody; Linda V Van Horn; Sudha Venkatramanan; Steven B Heymsfield Journal: JAMA Netw Open Date: 2021-08-02